2026년 9월 24일•1분 읽기
FDA Approves ANDA211623 for Generic Carbamazepine Extended‑Release Tablets
The FDA has approved ANDA211623 for carbamazepine extended‑release tablets (100 mg, 200 mg, 400 mg) submitted by Unique Pharm, with labeling cleared in Jan 2024.